George Roeth
Analyst · SunTrust. Please go ahead
Thank you, Steve. Good afternoon, everybody. Central's third quarter was the most successful third quarter in company history from a revenue and net income perspective. The quarter's total revenue growth of 12% was driven by strong organic growth and also aided by our Segrest and K&H acquisitions. Importantly, our organic sales growth was a robust 8% and reflected market share gains driven by strong consumer takeaway of our products. The favorable impact of the revenue growth and our realized cost saving more than offset an increase in demand creation spending and cost upgrade and expand the capacity and capabilities of some of our facilities. The result was a record Q3 profitability and a gain of EPS of 22% over the prior-year. Our strong Garden season was a key driver of our success in the quarter. The season has exceeded our expectations. We have driven market share gains and benefitted from weather that was favorable for our grass seed business. The Garden segments strength 15% sales growth encompassed almost all area, including our brands, private label and other manufacturer's products. Innovation, new listings and successful demand creation initiative drove significant revenue gains while earnings benefited from the operating leverage of higher volumes, as well as from our ongoing cost savings initiatives. The Pet side of the business posted its eight consecutive quarter of organic sales growth driven by our consumer brands. The strength of our diversified portfolio was born out by the fact that Pets delivered 2% overall organic sales growth despite lower sales of our animal health business and other manufacturers products. Our new acquisitions helped overall total Pet segment sales grow 9% but those additions did negatively impact our operating margin. Niko will give some detail on that in just a bit. We continue to make excellent progress on our strategic initiatives. Our cost savings and productivity efforts are moving along nicely. For example, during the quarter we opened our new 550,000 square foot packaging and distribution facility in New Jersey. These services are Nylabone, Fore Paws and IMS businesses and will help these business operate more efficiently and support continued sales growth for the foreseeable future. In addition, our Pet and Garden segments have a number of businesses that lower cost as we continue to optimize our insourcing, outsourcing mix. Moving beyond cost savings, our innovation activities are progressing as well and have played a significant part in this quarter's growth. This year we rolled up several new products in our Garden segment which has held growth sales significantly. For example, in a ray of new private label offering, spending several product areas and customers have performed well. We also added FDU [ph] and saw increased sales in some of our branded products like our AMDRO Quick Kill line. And finally we continue to work on building our strong customer focus and advancing our key retailer partnership. Beyond the private label products which we have talked about, we are partnering in marketing, promotion and category management activities to help our retail partners expand their sales and profits. For example, our Segrest acquisition which has made Central Garden & Pet's the only full line provider of aquatics products has afforded us the opportunity as high level discussions with our customers about partnering to drive store traffic and helps up penetration of our aquatics. On the acquisition front, Segrest continued to seed expectation and the K&H integration is on track although it is early in the integration process. Importantly, we continue to evaluate a healthy pipeline of acquisitions and joint venture candidate and are adding resources to continue to strengthen our team in this area. Overall for Q3 I think it's also important to mention that our earnings benefited from an increase below the line and other income. Due to the seasonal nature of JV we entered into this fiscal year. In the fourth quarter that benefit will be more than offset by loss from the same entity as there will be outer season. Next year over a full year as part of Central, we expect this investment to be accretive to earnings. As we mentioned on last quarter's earnings call, certain non-operating factors were expected to impact net income in the remainder of the year. Those factors include the seasonal JV I just mentioned, along with the second JV and higher corporate expenses versus the prior-year quarter which has benefited from lower insurance and payroll related expenses. We expect this impact to be felt in our fourth quarter which we will believe will cause our fourth quarter earnings to be below the prior year. We spoke of this last quarter and it's playing out as expected. Also keep in mind that the fourth quarter is relatively small for us from an earnings perspective, so money spending for future growth has a disproportionate impact on the EPS number. Net, net and in light of our strong third quarter performance and the factors I just detailed it impact our fourth quarter, we are raising our adjusted EPS projection to a $1.44 or higher. This includes any impact from our K&H acquisition. Now before I turn it over to Niko, I do want to acknowledge his recent and well-deserved promotion to Chief Financial Officer. Niko has tremendous operating knowledge of our businesses, and the financial acumen that the role demands. We are fortunate to have him in the seat in driving the business and with said, I will now turn over to Niko to go over the financial and get some more color on the quarter's results.